Published in Neurochem Int on December 07, 2008
Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis (2013) 1.62
Blood-brain barrier modeling with co-cultured neural progenitor cell-derived astrocytes and neurons. J Neurochem (2011) 1.51
In vitro modeling of the neurovascular environment by coculturing adult human brain endothelial cells with human neural stem cells. PLoS One (2014) 1.45
A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci Rep (2014) 1.38
Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat Commun (2015) 1.37
Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunol Rev (2012) 1.30
Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology (2010) 1.21
Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide. J Neuroinflammation (2011) 1.16
Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS (2013) 1.15
The blood-brain barrier: an engineering perspective. Front Neuroeng (2013) 1.09
Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult. J Cereb Blood Flow Metab (2010) 1.08
The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival. Fluids Barriers CNS (2011) 1.08
Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-α, releasing matrix metalloproteinase-9 and migrating in vitro. J Neuroinflammation (2011) 1.05
Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev (2014) 1.03
Monocyte chemoattractant protein-1 and the blood-brain barrier. Cell Mol Life Sci (2013) 1.02
Impedance-based cell monitoring: barrier properties and beyond. Fluids Barriers CNS (2013) 1.00
Infection of human pericytes by HIV-1 disrupts the integrity of the blood-brain barrier. J Cell Mol Med (2012) 0.99
Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia. Br J Pharmacol (2014) 0.98
Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models. PLoS One (2012) 0.98
Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor. Biomicrofluidics (2015) 0.94
Pharmacological inhibition of mitochondrial carbonic anhydrases protects mouse cerebral pericytes from high glucose-induced oxidative stress and apoptosis. J Pharmacol Exp Ther (2012) 0.94
Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier. BMC Neurosci (2013) 0.94
The blood-brain barrier permeability of geissoschizine methyl ether in Uncaria hook, a galenical constituent of the traditional Japanese medicine yokukansan. Cell Mol Neurobiol (2011) 0.93
A novel brain neurovascular unit model with neurons, astrocytes and microvascular endothelial cells of rat. Int J Biol Sci (2013) 0.92
Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation (2015) 0.92
Cell-based in vitro blood-brain barrier model can rapidly evaluate nanoparticles' brain permeability in association with particle size and surface modification. Int J Mol Sci (2014) 0.91
Brain pericytes: emerging concepts and functional roles in brain homeostasis. Cell Mol Neurobiol (2011) 0.91
The blood-brain barrier permeability of 18β-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yokukansan. Cell Mol Neurobiol (2012) 0.90
Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance. Brain Res (2012) 0.90
In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. J Cereb Blood Flow Metab (2016) 0.90
Role of non-neuronal cells in body weight and appetite control. Front Endocrinol (Lausanne) (2015) 0.89
The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier. Front Cell Neurosci (2014) 0.89
Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip. PLoS One (2016) 0.89
In vitro blood-brain barrier models using brain capillary endothelial cells isolated from neonatal and adult rats retain age-related barrier properties. PLoS One (2013) 0.89
Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels. Microvasc Res (2012) 0.88
Circulating brain microvascular endothelial cells (cBMECs) as potential biomarkers of the blood-brain barrier disorders caused by microbial and non-microbial factors. PLoS One (2013) 0.87
Triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegeneration. Oxid Med Cell Longev (2013) 0.87
LRP-1-mediated intracellular antibody delivery to the Central Nervous System. Sci Rep (2015) 0.86
Transient expression of iron transport proteins in the capillary of the developing rat brain. Cell Mol Neurobiol (2011) 0.86
Modeling the blood-brain barrier using stem cell sources. Fluids Barriers CNS (2013) 0.86
GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration. Antimicrob Agents Chemother (2013) 0.86
Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport. J Vis Exp (2014) 0.85
Cell-culture models of the blood-brain barrier. Stroke (2014) 0.85
Meningitic Escherichia coli K1 penetration and neutrophil transmigration across the blood-brain barrier are modulated by alpha7 nicotinic receptor. PLoS One (2011) 0.85
Impedance analysis of GPCR-mediated changes in endothelial barrier function: overview and fundamental considerations for stable and reproducible measurements. Pflugers Arch (2014) 0.84
Brain pericytes from stress-susceptible pigs increase blood-brain barrier permeability in vitro. Fluids Barriers CNS (2012) 0.84
Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage. Sci Rep (2015) 0.84
Low dose cranial irradiation-induced cerebrovascular damage is reversible in mice. PLoS One (2014) 0.83
Infection of pericytes in vitro by Japanese encephalitis virus disrupts the integrity of the endothelial barrier. J Virol (2013) 0.83
Co-transplantation of hippocampal neural stem cells and astrocytes and microvascular endothelial cells improve the memory in ischemic stroke rat. Int J Clin Exp Med (2015) 0.83
CORM-A1 prevents blood-brain barrier dysfunction caused by ionotropic glutamate receptor-mediated endothelial oxidative stress and apoptosis. Am J Physiol Cell Physiol (2013) 0.83
EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference. PLoS One (2013) 0.82
Toxoplasma gondii and the blood-brain barrier. Virulence (2012) 0.82
Cultured cells of the blood-brain barrier from apolipoprotein B-100 transgenic mice: effects of oxidized low-density lipoprotein treatment. Fluids Barriers CNS (2015) 0.82
A Novel Dynamic Neonatal Blood-Brain Barrier on a Chip. PLoS One (2015) 0.82
Optimization of endothelial cell growth in a murine in vitro blood-brain barrier model. Biotechnol J (2011) 0.81
Pitavastatin strengthens the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol (2010) 0.81
Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model. Cell Mol Neurobiol (2013) 0.81
Influence of basement membrane proteins and endothelial cell-derived factors on the morphology of human fetal-derived astrocytes in 2D. PLoS One (2014) 0.81
A novel in vitro model to study pericytes in the neurovascular unit of the developing cortex. PLoS One (2013) 0.81
Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis. PLoS One (2015) 0.80
Plasma from patients with HELLP syndrome increases blood-brain barrier permeability. Reprod Sci (2014) 0.80
A composite model of the human postcapillary venule for investigation of microvascular leukocyte recruitment. FASEB J (2013) 0.80
Prostacyclin prevents pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system. J Biol Chem (2015) 0.79
C-type natriuretic peptide modulates permeability of the blood-brain barrier. J Cereb Blood Flow Metab (2014) 0.79
Cilostazol strengthens barrier integrity in brain endothelial cells. Cell Mol Neurobiol (2012) 0.79
In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain. Int J Nanomedicine (2012) 0.79
Human astrocytes develop physiological morphology and remain quiescent in a novel 3D matrix. Biomaterials (2014) 0.79
Silver nanoparticles induce tight junction disruption and astrocyte neurotoxicity in a rat blood-brain barrier primary triple coculture model. Int J Nanomedicine (2015) 0.79
An Isogenic Blood-Brain Barrier Model Comprising Brain Endothelial Cells, Astrocytes and Neurons Derived from Human Induced Pluripotent Stem Cells. J Neurochem (2016) 0.78
Hyperbaric oxygen preconditioning ameliorates blood-brain barrier damage induced by hypoxia through modulation of tight junction proteins in an in vitro model. Croat Med J (2016) 0.78
A distinct mechanism of vascular lumen formation in Xenopus requires EGFL7. PLoS One (2015) 0.78
A dynamic in vivo-like organotypic blood-brain barrier model to probe metastatic brain tumors. Sci Rep (2016) 0.77
In vitro model of the blood-brain barrier established by co-culture of primary cerebral microvascular endothelial and astrocyte cells. Neural Regen Res (2015) 0.77
Pericytes contribute to the disruption of the cerebral endothelial barrier via increasing VEGF expression: implications for stroke. PLoS One (2015) 0.77
A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes. PLoS One (2015) 0.77
A DKP cyclo(L-Phe-L-Phe) found in chicken essence is a dual inhibitor of the serotonin transporter and acetylcholinesterase. PLoS One (2012) 0.77
Barrier functionality of porcine and bovine brain capillary endothelial cells. Bioimpacts (2011) 0.77
Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier properties. Fluids Barriers CNS (2015) 0.77
Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability. Cytotechnology (2012) 0.77
Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro. Cell Mol Neurobiol (2014) 0.76
A novel tricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor, GRL-0739, effectively inhibits the replication of multidrug-resistant HIV-1 variants and has a desirable central nervous system penetration property in vitro. Antimicrob Agents Chemother (2015) 0.76
P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models. PLoS One (2014) 0.75
Optimization of an in vitro human blood-brain barrier model: Application to blood monocyte transmigration assays. MethodsX (2015) 0.75
Effects of Muscone on the Expression of P-gp, MMP-9 on Blood-Brain Barrier Model In Vitro. Cell Mol Neurobiol (2015) 0.75
Passage of Magnetic Tat-Conjugated Fe3O4@SiO2 Nanoparticles Across In Vitro Blood-Brain Barrier. Nanoscale Res Lett (2016) 0.75
In Vitro Modeling of Blood-Brain Barrier with Human iPSC-Derived Endothelial Cells, Pericytes, Neurons, and Astrocytes via Notch Signaling. Stem Cell Reports (2017) 0.75
Vimentin, a Novel NF-κB Regulator, Is Required for Meningitic Escherichia coli K1-Induced Pathogen Invasion and PMN Transmigration across the Blood-Brain Barrier. PLoS One (2016) 0.75
A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413. Antimicrob Agents Chemother (2016) 0.75
The small molecule AUTEN-99 (autophagy enhancer-99) prevents the progression of neurodegenerative symptoms. Sci Rep (2017) 0.75
An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1. AAPS J (2014) 0.75
Neuroprotective Effect of Salvianolic Acids against Cerebral Ischemia/Reperfusion Injury. Int J Mol Sci (2016) 0.75
Hydrocortisone enhances the barrier properties of HBMEC/ciβ, a brain microvascular endothelial cell line, through mesenchymal-to-endothelial transition-like effects. Fluids Barriers CNS (2015) 0.75
Aggregation is a critical cause of poor transfer into the brain tissue of intravenously administered cationic PAMAM dendrimer nanoparticles. Int J Nanomedicine (2017) 0.75
Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells. Front Pharmacol (2017) 0.75
Brain endothelial cells induce astrocytic expression of the glutamate transporter GLT-1 by a Notch-dependent mechanism. J Neurochem (2017) 0.75
Antibody blood-brain barrier efflux is modulated by glycan modification. Biochim Biophys Acta (2017) 0.75
IFN-γ promotes transendothelial migration of CD4(+) T cells across the blood-brain barrier. Immunol Cell Biol (2017) 0.75
Effect of magnolol on cerebral injury and blood brain barrier dysfunction induced by ischemia-reperfusion in vivo and in vitro. Metab Brain Dis (2017) 0.75
Effect of shear stress on iPSC-derived human brain microvascular endothelial cells (dhBMECs). Fluids Barriers CNS (2017) 0.75
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci (2011) 5.42
Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood (2010) 3.15
Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol (2005) 2.58
Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles (2013) 2.08
Antibacterial effect of microvesicles released from human neutrophilic granulocytes. Blood (2012) 1.76
Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production. Brain Res (2005) 1.76
Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol (2007) 1.68
A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol (2002) 1.59
HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res (2003) 1.43
Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells. J Cereb Blood Flow Metab (2005) 1.33
14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol (2006) 1.23
Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases. PLoS One (2012) 1.14
Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism. J Immunol (2004) 1.11
The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J Cereb Blood Flow Metab (2007) 1.10
Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier. Regul Pept (2004) 1.10
Expression pattern of inositol phosphate-related enzymes in rice (Oryza sativa L.): implications for the phytic acid biosynthetic pathway. Gene (2007) 1.09
Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine. J Immunol (2003) 1.07
Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages. Neurochem Int (2006) 1.06
Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB/c mice. J Proteomics (2011) 1.02
Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer. Cell Mol Neurobiol (2002) 1.01
Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Mol Pain (2010) 1.00
Intracellular transport of Toxoplasma gondii through the blood-brain barrier. J Neuroimmunol (2010) 0.98
Patented in vitro blood-brain barrier models in CNS drug discovery. Recent Pat CNS Drug Discov (2011) 0.98
Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells. PLoS One (2012) 0.98
Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models. Eur J Pharm Biopharm (2012) 0.95
Spatial correlation between submillimetre and Lyman-alpha galaxies in the SSA 22 protocluster. Nature (2009) 0.95
Highly effective recombinant format of a humanized IgG-like bispecific antibody for cancer immunotherapy with retargeting of lymphocytes to tumor cells. J Biol Chem (2007) 0.94
Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5. Cell Mol Neurobiol (2006) 0.93
A major role for non-major histocompatibility complex genes but not for microorganisms in a novel murine model of Graves' hyperthyroidism. Thyroid (2003) 0.93
A novel type of implantable and programmable infusion pump for small laboratory animals. J Pharmacol Toxicol Methods (2008) 0.93
Transient forebrain ischemia increases the blood-brain barrier permeability for albumin in stroke-prone spontaneously hypertensive rats. Cell Mol Neurobiol (2002) 0.92
Expression of MCP-1 in the hippocampus of SHRSP with ischemia-related delayed neuronal death. Cell Mol Neurobiol (2006) 0.92
DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats. J Neurochem (2008) 0.91
Max is a repressor of germ cell-related gene expression in mouse embryonic stem cells. Nat Commun (2013) 0.91
Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier. Cell Mol Neurobiol (2004) 0.91
Lower body negative pressure exercise plus brief postexercise lower body negative pressure improve post-bed rest orthostatic tolerance. J Appl Physiol (1985) (2007) 0.91
Application of the Fc fusion format to generate tag-free bi-specific diabodies. FEBS J (2009) 0.90
Oxygen-glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood-brain barrier. Neurochem Int (2011) 0.90
Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts. Arthritis Res Ther (2009) 0.89
Comparison of the interaction of human organic anion transporter hOAT4 with PDZ proteins between kidney cells and placental cells. Pharm Res (2007) 0.89
A pitfall in diagnosis of human prion diseases using detection of protease-resistant prion protein in urine. Contamination with bacterial outer membrane proteins. J Biol Chem (2004) 0.89
Human organic anion transporter hOAT1 forms homooligomers. J Biol Chem (2005) 0.89
Kinetic analysis of the toxicity of pharmaceutical excipients Cremophor EL and RH40 on endothelial and epithelial cells. J Pharm Sci (2013) 0.88
Detection of hypothalamic activation by manganese ion contrasted T(1)-weighted magnetic resonance imaging in rats. Neurosci Lett (2002) 0.88
Applicability of sucrose laurate as surfactant in solid dispersions prepared by melt technology. Int J Pharm (2011) 0.87
Long-term hypergravity induces plastic alterations in vestibulo-cardiovascular reflex in conscious rats. Neurosci Lett (2006) 0.86
Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment. Free Radic Biol Med (2005) 0.86
Impairment of vestibular-mediated cardiovascular response and motor coordination in rats born and reared under hypergravity. Am J Physiol Regul Integr Comp Physiol (2008) 0.86
Vestibular-mediated increase in central serotonin plays an important role in hypergravity-induced hypophagia in rats. J Appl Physiol (1985) (2010) 0.85
Neurochemical Changes in the Mouse Hippocampus Underlying the Antidepressant Effect of Genetic Deletion of P2X7 Receptors. PLoS One (2013) 0.85
Characterization of an organic anion transport system in a placental cell line. Am J Physiol Endocrinol Metab (2003) 0.85
Neuroprotective effect of pentosan polysulphate on ischemia-related neuronal death of the hippocampus. Neurosci Lett (2006) 0.85
Toxicity of quinacrine can be reduced by co-administration of P-glycoprotein inhibitor in sporadic Creutzfeldt-Jakob disease. Cell Mol Neurobiol (2004) 0.85
The role of glycine residues in the function of human organic anion transporter 4. Mol Pharmacol (2004) 0.85
ATP and ATPase secretion by exocrine pancreas in rat, guinea pig, and human. Pancreas (2004) 0.85
The role of purinergic signaling in depressive disorders. Neuropsychopharmacol Hung (2012) 0.84
The effect of sucrose esters on a culture model of the nasal barrier. Toxicol In Vitro (2012) 0.84
Modulation of neurotransmitter release by P2X and P2Y receptors in the rat spinal cord. Neuropharmacology (2007) 0.84
Tissue plasminogen activator enhances the hypoxia/reoxygenation-induced impairment of the blood-brain barrier in a primary culture of rat brain endothelial cells. Cell Mol Neurobiol (2008) 0.84
Functional role of the C terminus of human organic anion transporter hOAT1. J Biol Chem (2006) 0.83
Highly enhanced cytotoxicity of a dimeric bispecific diabody, the hEx3 tetrabody. J Biol Chem (2010) 0.83
Strong galvanic vestibular stimulation obscures arterial pressure response to gravitational change in conscious rats. J Appl Physiol (1985) (2007) 0.83
Protection of the blood-brain barrier by pentosan against amyloid-β-induced toxicity. J Alzheimers Dis (2010) 0.83
Galvanic vestibular stimulation counteracts hypergravity-induced plastic alteration of vestibulo-cardiovascular reflex in rats. J Appl Physiol (1985) (2009) 0.83
Effect of nicotine and polyaromtic hydrocarbons on cerebral endothelial cells. Cell Biol Int (2007) 0.83
Docosahexaenoic acid reduces amyloid-β induced toxicity in cells of the neurovascular unit. J Alzheimers Dis (2013) 0.83
Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue. Eur J Pharm Biopharm (2008) 0.83
Randomly methylated β-cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco-2 cell monolayer. J Pharm Sci (2011) 0.83
Pentosan reduces osteonecrosis of femoral head in SHRSP. Clin Exp Hypertens (2010) 0.83
Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease. Mol Neurodegener (2011) 0.82
Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis. Immunol Lett (2010) 0.82
Human immunodeficiency virus type 1 transport across the in vitro mouse brain endothelial cell monolayer. Exp Neurol (2005) 0.82
Diabody-based recombinant formats of humanized IgG-like bispecific antibody with effective retargeting of lymphocytes to tumor cells. J Immunother (2008) 0.82
Activation of dorsolateral prefrontal cortex in a dual neuropsychological screening test: an fMRI approach. Behav Brain Funct (2012) 0.82
Adrenomedullin, an autocrine mediator of blood-brain barrier function. Hypertens Res (2003) 0.81
Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model. Cell Mol Neurobiol (2013) 0.81
P2Y receptor mediated inhibitory modulation of noradrenaline release in response to electrical field stimulation and ischemic conditions in superfused rat hippocampus slices. J Neurochem (2008) 0.81
Human serum amyloid P component attenuates the bacterial lipopolysaccharide-induced increase in blood-brain barrier permeability in mice. Neurosci Lett (2003) 0.81
Effect of unpleasant loud noise on hippocampal activities during picture encoding: an fMRI study. Brain Cogn (2006) 0.81
Determination of the external loops and the cellular orientation of the N- and the C-termini of the human organic anion transporter hOAT1. Biochem J (2007) 0.81
Metoclopramide causes airway smooth muscle relaxation through inhibition of muscarinic M3 receptor in the rat trachea. Anesth Analg (2004) 0.81
Pitavastatin strengthens the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol (2010) 0.81
Osteonecrosis of femoral head in the stroke-prone spontaneously hypertensive rats, especially old rats. Clin Exp Hypertens (2008) 0.80
Evidence for vestibular dysfunction in orthostatic hypotension. Exp Brain Res (2011) 0.80
Sequence of forebrain activation induced by intraventricular injection of hypertonic NaCl detected by Mn2+ contrasted T1-weighted MRI. Auton Neurosci (2004) 0.80
In vitro and in vivo antitumor effects of recombinant bispecific antibodies based on humanized anti-EGFR antibody. Oncol Rep (2011) 0.80